Laboratory Corporation of America Holdings Future Growth
Future criteria checks 1/6
Laboratory of America Holdings is forecasted to grow earnings and revenue by 9.8% and 3.6% per annum respectively. EPS is expected to grow by 9.3%. Return on equity is forecast to be 15% in 3 years.
Key information
9.8%
Earnings growth rate
9.3%
EPS growth rate
| Healthcare earnings growth | 13.3% |
| Revenue growth rate | 3.6% |
| Future return on equity | 15.0% |
| Analyst coverage | Good |
| Last updated | 19 May 2023 |
Recent future growth updates
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Recent updates
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26We Think Laboratory Corporation of America Holdings (NYSE:LH) Can Stay On Top Of Its Debt
Oct 14Laboratory Corporation of America declares $0.72 dividend
Oct 12Is Laboratory Corporation of America Holdings (NYSE:LH) Potentially Undervalued?
Sep 28LabCorp to pay $273M to company for infringing prenatal test patents - Bloomberg
Sep 23LabCorp: Drug Development Segment Spinoff Poised To Generate Significant Value
Aug 23Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)
Aug 22Laboratory Corp: The Force Is Strong With This One
Aug 17Labcorp plans to spinoff clinical drug trials and development business - WSJ
Jul 28Labcorp expands automated clinical trial kit production line at Belgium facility
Jul 18Laboratory Corporation of America Holdings (NYSE:LH) Has A Pretty Healthy Balance Sheet
Jul 15Labcorp to partner with a Spanish cancer research center for oncology clinical trials
Jul 11Is Now An Opportune Moment To Examine Laboratory Corporation of America Holdings (NYSE:LH)?
Jun 30Laboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share
Jun 05Returns On Capital Are Showing Encouraging Signs At Laboratory Corporation of America Holdings (NYSE:LH)
May 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 11What Is Laboratory Corporation of America Holdings's (NYSE:LH) Share Price Doing?
Mar 30Laboratory Corporation Of America: An Undervalued Play In The Life Sciences Space
Mar 20Should You Be Adding Laboratory Corporation of America Holdings (NYSE:LH) To Your Watchlist Today?
Mar 18Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Quite Sensibly
Mar 06Returns on Capital Paint A Bright Future For Laboratory Corporation of America Holdings (NYSE:LH)
Feb 06Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 37%?
Jan 11Is It Time To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
Dec 30Here's Why We Think Laboratory Corporation of America Holdings (NYSE:LH) Is Well Worth Watching
Dec 17Is Laboratory Corporation of America Holdings (NYSE:LH) Using Too Much Debt?
Dec 05Investors Shouldn't Overlook Laboratory Corporation of America Holdings' (NYSE:LH) Impressive Returns On Capital
Oct 30Why Laboratory Corporation of America Holdings (NYSE:LH) Could Be Worth Watching
Sep 22Here's Why I Think Laboratory Corporation of America Holdings (NYSE:LH) Is An Interesting Stock
Sep 09Laboratory Corporation of America Holdings (NYSE:LH) Seems To Use Debt Rather Sparingly
Aug 27Labcorp Is Up 61% And Looks Set For More Growth
Aug 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 16,450 | 1,507 | 1,744 | 2,314 | 9 |
| 12/31/2024 | 15,892 | 1,344 | 1,507 | 2,061 | 15 |
| 12/31/2023 | 15,224 | 1,190 | 1,215 | 1,742 | 15 |
| 3/31/2020 | 11,587 | 321 | 1,070 | 1,483 | N/A |
| 12/31/2019 | 11,555 | 824 | 1,045 | 1,445 | N/A |
| 9/30/2019 | 11,389 | 755 | 967 | 1,361 | N/A |
| 6/30/2019 | 11,292 | 853 | 758 | 1,158 | N/A |
| 3/31/2019 | 11,276 | 896 | 890 | 1,292 | N/A |
| 12/31/2018 | 11,333 | 884 | 926 | 1,305 | N/A |
| 9/30/2018 | 11,291 | 1,414 | 1,030 | 1,384 | N/A |
| 6/30/2018 | 11,081 | 1,266 | 1,198 | 1,529 | N/A |
| 3/31/2018 | 10,743 | 1,217 | 1,137 | 1,452 | N/A |
| 12/31/2017 | 10,308 | 1,227 | 1,183 | 1,498 | N/A |
| 9/30/2017 | 9,951 | 724 | 1,089 | 1,382 | N/A |
| 6/30/2017 | 9,702 | 732 | 951 | 1,235 | N/A |
| 3/31/2017 | 9,556 | 751 | 993 | 1,274 | N/A |
| 12/31/2016 | 9,553 | 712 | N/A | 1,197 | N/A |
| 9/30/2016 | 9,295 | 658 | N/A | 1,112 | N/A |
| 6/30/2016 | 9,192 | 633 | N/A | 1,150 | N/A |
| 3/31/2016 | 9,029 | 599 | N/A | 1,197 | N/A |
| 12/31/2015 | 8,506 | 438 | N/A | 982 | N/A |
| 9/30/2015 | 7,774 | 447 | N/A | 812 | N/A |
| 6/30/2015 | 7,056 | 430 | N/A | 699 | N/A |
| 3/31/2015 | 6,353 | 401 | N/A | 510 | N/A |
| 12/31/2014 | 6,012 | 511 | N/A | 739 | N/A |
| 9/30/2014 | 5,936 | 518 | N/A | 774 | N/A |
| 6/30/2014 | 5,846 | 529 | N/A | 833 | N/A |
| 3/31/2014 | 5,798 | 540 | N/A | 763 | N/A |
| 12/31/2013 | 5,808 | 574 | N/A | 819 | N/A |
| 9/30/2013 | 5,777 | 568 | N/A | 824 | N/A |
| 6/30/2013 | 5,734 | 567 | N/A | 794 | N/A |
| 3/31/2013 | 5,689 | 569 | N/A | 843 | N/A |
| 12/31/2012 | 5,671 | 583 | N/A | 841 | N/A |
| 9/30/2012 | 5,632 | 598 | N/A | 866 | N/A |
| 6/30/2012 | 5,617 | 585 | N/A | 839 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LH's forecast earnings growth (9.8% per year) is above the savings rate (2.1%).
Earnings vs Market: LH's earnings (9.8% per year) are forecast to grow slower than the US market (15.5% per year).
High Growth Earnings: LH's earnings are forecast to grow, but not significantly.
Revenue vs Market: LH's revenue (3.6% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: LH's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LH's Return on Equity is forecast to be low in 3 years time (15%).